HIV/AIDS News and Research RSS Feed - HIV/AIDS News and Research Twitter

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

This condition progressively reduces the effectiveness of the immune system and leaves individuals susceptible to opportunistic infections and tumors. HIV is transmitted through direct contact of a mucous membrane or the bloodstream with a bodily fluid containing HIV, such as blood, semen, vaginal fluid, preseminal fluid, and breast milk.
UH GCSW receives NIH grant to study health consequences of heroin use

UH GCSW receives NIH grant to study health consequences of heroin use

The University of Houston Graduate College of Social Work is the recipient of a 5-year, $1.25 million grant from the National Institute of Drug Abuse at the National Institutes of Health to study the long-term use and health consequences of heroin use. [More]
FDA accepts Mylan's ANDA filing for generic Copaxone 40 mg/mL

FDA accepts Mylan's ANDA filing for generic Copaxone 40 mg/mL

Mylan Inc. today announced that its abbreviated new drug application (ANDA) for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration. [More]
Cilag GmbH International acquires biopharmaceutical company, Covagen AG

Cilag GmbH International acquires biopharmaceutical company, Covagen AG

Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired Covagen AG, a privately-held, biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb® technology platform. [More]
FDA approves ViiV Healthcare's Triumeq tablets for treatment of HIV-1 infection

FDA approves ViiV Healthcare's Triumeq tablets for treatment of HIV-1 infection

ViiV Healthcare announced today that the US Food and Drug Administration has approved Triumeq (abacavir 600mg, dolutegravir 50mg and lamivudine 300mg) tablets for the treatment of HIV-1 infection. [More]
Mylan launches Potassium Chloride Extended-release Tablets

Mylan launches Potassium Chloride Extended-release Tablets

Mylan Inc. today announced that it has launched Potassium Chloride Extended-release Tablets USP, 8 mEq (600 mg) and 10 mEq (750 mg), which is the generic version of Upsher-Smith's Klor-Con. [More]
Fungal infections that sicken HIV/AIDS patients grow on trees

Fungal infections that sicken HIV/AIDS patients grow on trees

Researchers have pinpointed the environmental source of fungal infections that have been sickening HIV/AIDS patients in Southern California for decades. It literally grows on trees. [More]
Prenatal care for pregnant women increases from 61 to 91.3%, highlights Equatorial Guinea

Prenatal care for pregnant women increases from 61 to 91.3%, highlights Equatorial Guinea

Equatorial Guinea's infant mortality rate has decreased from 111 in 1994 to 65 per one thousand in 2011, said the country's Health Secretary of State, Maria del Carmen Andeme Ela. She also reported that the percentage of pregnant women receiving prenatal care from skilled health personnel has increase from 61% in 2000 to 91.3% this year. [More]
Some states angered about lack of authority over Medicare advantage plans

Some states angered about lack of authority over Medicare advantage plans

Elsewhere, Medicare officials consider offering HIV tests for all Medicare beneficiaries. Swanson turned to CMS because state regulators lack the legal authority to impose sanctions on Medicare Advantage carriers. [More]
Study: Patients with 2 or more ED visits in one year account for disproportionate costs

Study: Patients with 2 or more ED visits in one year account for disproportionate costs

Almost one-third of acute heart failure syndrome patients seen in hospital emergency departments (EDs) in Florida and California during 2010 had ED visits during the following year, findings that suggest a lack of appropriate outpatient care. [More]
MGH-developed microfluidic device may help study key steps involved in development of tumor metastasis

MGH-developed microfluidic device may help study key steps involved in development of tumor metastasis

A microfluidic device developed at Massachusetts General Hospital may help study key steps in the process by which cancer cells break off from a primary tumor to invade other tissues and form metastases. [More]
Research and planning to meet health needs of people living with HIV

Research and planning to meet health needs of people living with HIV

As effective treatments for HIV become more widely available in low- and middle-income countries, there's an urgent need to assess and manage health risks in the growing number of people living with HIV. [More]
MRSA and antibiotic resistance is a major health threat

MRSA and antibiotic resistance is a major health threat

Antibiotic resistance continues at an alarming rate with the indiscriminate overuse of antibiotics given to humans and animals. [More]
Mylan announces launch of Capecitabine Tablets USP, 150 mg and 500 mg

Mylan announces launch of Capecitabine Tablets USP, 150 mg and 500 mg

Mylan Inc. today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated as monotherapy, adjuvant therapy and combination therapy for certain types of breast, colon and colorectal cancers. [More]

Racial differences in life expectancy vary substantially across U.S. states

Racial differences in life expectancy have declined nationally but still vary substantially across U.S. states, according to a new study by McGill University researchers. [More]
Laboratories at TSRI investigate antibodies to fight Ebola virus

Laboratories at TSRI investigate antibodies to fight Ebola virus

Laboratories at The Scripps Research Institute (TSRI) are investigating antibodies to fight Ebola virus, including the three antibodies recently used to treat two American health care workers infected with the Ebola virus. [More]
Herpes zoster vaccine effective in protecting older adults against shingles, even after chemotherapy

Herpes zoster vaccine effective in protecting older adults against shingles, even after chemotherapy

The herpes zoster vaccine continues to be effective in protecting older adults against shingles, even after they undergo chemotherapy, according to a Kaiser Permanente study published today in the journal Clinical Infectious Diseases. [More]
Medical education in sub-Saharan Africa is being revitalized through U.S. funded effort

Medical education in sub-Saharan Africa is being revitalized through U.S. funded effort

Medical education in sub-Saharan Africa is being revitalized and expanded through a U.S.-funded effort that is dramatically increasing enrollment, broadening curricula, upgrading Internet access and providing cutting-edge skills labs and other technologies. [More]
Johns Hopkins School of Nursing to launch new HIV curriculum for non-physician providers

Johns Hopkins School of Nursing to launch new HIV curriculum for non-physician providers

The 31-year-old Moore Clinic operated by the Johns Hopkins AIDS Service at the School of Medicine is a historic operation — the second-oldest AIDS clinic in the country. But when Jason Farley, PhD, MPH, CRNP, looks nowadays at the makeup of Moore's caregiving staff, he worries that he's seeing too much history. [More]
U.S.-funded effort revitalizes, expands medical education in sub-Saharan Africa

U.S.-funded effort revitalizes, expands medical education in sub-Saharan Africa

Medical education in sub-Saharan Africa is being revitalized and expanded through a U.S.-funded effort that is dramatically increasing enrollment, broadening curricula, upgrading Internet access and providing cutting-edge skills labs and other technologies. [More]
EGPAF and ACS partner to improve access to essential pain medications for HIV people

EGPAF and ACS partner to improve access to essential pain medications for HIV people

Today the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and the American Cancer Society (ACS) announced a new partnership to improve access to essential pain medications for people living with HIV in Swaziland. [More]